Trump administration: States to decide which hospitals gets Gilead's COVID-19 drug

After a week of confusion and criticism, the Trump administration over the weekend said states would take the lead in allocating to hospitals supplies of Gilead's COVID-19 drug remdesivir, which was recently shown in a clinical trial to hasten recovery from the disease caused by the new coronavirus.